Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Vitetta

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Brain Communications|June 25, 2021
Gut-brain axis in the neurological comorbidity of COVID-19Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences|July 29, 2020
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic ImplicationsJiezhong Chen, Luis Vitetta
Integrative Cancer Therapies|August 24, 2018
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced MucositisMichael Thomsen, Luis Vitetta
Australian Family Physician|May 9, 2006
Colorectal cancer and CHF - reviewing the evidence for complementary medicineLuis Vitetta, Avni Sali
Australian Family Physician|March 7, 2007
Integrative medicine in gynaecological cancersAvni Sali, Luis Vitetta
Journal of Clinical Medicine|July 2, 2021
Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19Jiezhong Chen, Luis Vitetta
Frontiers in Bioscience (Scholar Edition)|September 22, 2022
The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical OutcomesJiezhong Chen, Luis Vitetta
Clinical Immunology (Orlando, Fla.)|October 3, 2021
Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19Jiezhong Chen, Luis Vitetta
European Journal of Gastroenterology & Hepatology|September 24, 2021
The gut-liver axis in chronic liver disease associated with severe COVID-19Jiezhong Chen, Luis Vitetta
Clinical and Translational Gastroenterology|January 26, 2022
Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19Jiezhong Chen, Luis Vitetta
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Brain Communications|June 25, 2021
Gut-brain axis in the neurological comorbidity of COVID-19Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences|July 29, 2020
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic ImplicationsJiezhong Chen, Luis Vitetta
Integrative Cancer Therapies|August 24, 2018
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced MucositisMichael Thomsen, Luis Vitetta
Australian Family Physician|May 9, 2006
Colorectal cancer and CHF - reviewing the evidence for complementary medicineLuis Vitetta, Avni Sali
Australian Family Physician|March 7, 2007
Integrative medicine in gynaecological cancersAvni Sali, Luis Vitetta
Journal of Clinical Medicine|July 2, 2021
Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19Jiezhong Chen, Luis Vitetta
Frontiers in Bioscience (Scholar Edition)|September 22, 2022
The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical OutcomesJiezhong Chen, Luis Vitetta
Clinical Immunology (Orlando, Fla.)|October 3, 2021
Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19Jiezhong Chen, Luis Vitetta
European Journal of Gastroenterology & Hepatology|September 24, 2021
The gut-liver axis in chronic liver disease associated with severe COVID-19Jiezhong Chen, Luis Vitetta
Clinical and Translational Gastroenterology|January 26, 2022
Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19Jiezhong Chen, Luis Vitetta
Pageof 15